Basic Information
| RNALocate ID: | RLID:11001850 |
| RNA Symbol: | hsa-miR-9-5p |
| Localization: | Exosome |
RNA Information
| RNA Name: | hsa-miR-9-5p |
| RNA ID: | miRBase:MIMAT0000441 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 23663360 |
| Tissue/Cell Line: | Plasma |
| Method: | Next-generation RNA sequencing |
| Description: | Because the abundance of most miRNAs is low in the exosomes, we defined detectable miRNAs as those that had at least one sequence per million mappable miRNA reads. Accordingly, we detected a total of 593 known miRNAs in the 14 libraries. In each individual library, the number of detectable known miRNAs varied from 380 to 474 with an average of 419 [see Additional file 2]. Data are collected from Additional file 2: Read counts of the miRNAs detected in the 14 libraries (normalized to read number per million mappable miRNA seqeuences). |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01001806 | Cytoplasm | Nasopharyngeal carcinoma cells | 20498841 |
| RLID:01001807 | Mitochondrion | Cell line (HEK-293) | 22984580 |
| RLID:01001808 | Nucleus | Nasopharyngeal carcinoma cells | 20498841 |
| RLID:11001847 | Exosome | Hepatocellular carcinoma cell line (HepG2)|Lung epithelial carcinoma cell line (A549) | 20615901 |
| RLID:11001848 | Exosome | B cell line (Raji)|Jurkat-derived T cell line (J77cl20) | 21505438 |
| RLID:11001849 | Exosome | Brain tissue | 23382797 |
| RLID:11001851 | Exosome | Human mast cell line (HMC-1) | 24009880 |
| RLID:11001852 | Microvesicle | Hepatocellular carcinoma cell line (HepG2)|Lung epithelial carcinoma cell line (A549) | 20615901 |
| RLID:11001853 | Microvesicle | Cerebrospinal fluid | 24797360 |
| RLID-D:11000089 | Exosome | Blood|Chronic lymphocytic leukemia cells|Tongue tissue | |
| RLID-D:11000369 | Microvesicle | Blood|Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-9-5p | Disease of metabolism | MNDR-E-MI-72441 |
| MNDR | hsa-miR-9-5p | Splenic marginal zone lymphoma | MNDR-E-MI-72442 |
| MNDR | hsa-miR-9-5p | Multiple sclerosis chronic progressive | MNDR-E-MI-72443 |
| MNDR | hsa-miR-9-5p | Oral squamous cell carcinoma | MNDR-E-MI-72444 |
| MNDR | hsa-miR-9-5p | Large cell neuroendocrine cancer | MNDR-E-MI-72445 |
| MNDR | hsa-miR-9-5p | Follicular lymphoma | MNDR-E-MI-72446 |
| MNDR | hsa-miR-9-5p | Medulloblastoma | MNDR-E-MI-72447 |
| MNDR | hsa-miR-9-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-72448 |
| MNDR | hsa-miR-9-5p | Lymphoma | MNDR-E-MI-72449 |
| MNDR | hsa-miR-9-5p | Lymphoma non-hodgkin | MNDR-E-MI-72450 |
| MNDR | hsa-miR-9-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-72451 |
| MNDR | hsa-miR-9-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-72452 |
| MNDR | hsa-miR-9-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-72453 |
| MNDR | hsa-miR-9-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-72454 |
| MNDR | hsa-miR-9-5p | Her2-receptor positive breast cancer | MNDR-E-MI-72455 |
| MNDR | hsa-miR-9-5p | Triple negative breast cancer | MNDR-E-MI-72456 |
| MNDR | hsa-miR-9-5p | Anencephaly | MNDR-E-MI-72457 |
| MNDR | hsa-miR-9-5p | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-72458 |
| MNDR | hsa-miR-9-5p | Gastric cancer | MNDR-E-MI-72459 |
| MNDR | hsa-miR-9-5p | Gastric lymphoma | MNDR-E-MI-72460 |
| MNDR | hsa-miR-9-5p | Alzheimer disease | MNDR-E-MI-72461 |
| MNDR | hsa-miR-9-5p | Intracranial aneurysm | MNDR-E-MI-72462 |
| MNDR | hsa-miR-9-5p | Urinary bladder cancer | MNDR-E-MI-72463 |
| MNDR | hsa-miR-9-5p | Sarcoma | MNDR-E-MI-72464 |
| MNDR | hsa-miR-9-5p | Dysautonomia familial | MNDR-E-MI-72465 |
| MNDR | hsa-miR-9-5p | Seizures | MNDR-E-MI-72466 |
| MNDR | hsa-miR-9-5p | Friedreich ataxia | MNDR-E-MI-72467 |
| MNDR | hsa-miR-9-5p | Huntington disease | MNDR-E-MI-72468 |
| MNDR | hsa-miR-9-5p | Chorea | MNDR-E-MI-72469 |
| MNDR | hsa-miR-9-5p | Lung cancer | MNDR-E-MI-72470 |
| MNDR | hsa-miR-9-5p | Endometrial cancer | MNDR-E-MI-72471 |
| MNDR | hsa-miR-9-5p | Down syndrome | MNDR-E-MI-72472 |
| MNDR | hsa-miR-9-5p | Parkinson disease | MNDR-E-MI-72473 |
| MNDR | hsa-miR-9-5p | Basal-like breast cancer | MNDR-E-MI-72474 |
| MNDR | hsa-miR-9-5p | Squamous cell carcinoma | MNDR-E-MI-72475 |
| MNDR | hsa-miR-9-5p | Thyroid cancer | MNDR-E-MI-72476 |
| MNDR | hsa-miR-9-5p | Malignant mesothelioma | MNDR-E-MI-72477 |
| MNDR | hsa-miR-9-5p | Pancreatic cancer | MNDR-E-MI-72478 |
| MNDR | hsa-miR-9-5p | Malignant melanoma | MNDR-E-MI-72479 |
| MNDR | hsa-miR-9-5p | Colon cancer | MNDR-E-MI-72480 |
| MNDR | hsa-miR-9-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-72481 |
| MNDR | hsa-miR-9-5p | Familial ovarian cancer | MNDR-E-MI-72482 |
| MNDR | hsa-miR-9-5p | Prostate adenocarcinoma | MNDR-E-MI-72483 |
| MNDR | hsa-miR-9-5p | Laryngeal squamous cell carcinoma | MNDR-E-MI-72484 |
| MNDR | hsa-miR-9-5p | Carcinoma ductal breast | MNDR-E-MI-72485 |
| MNDR | hsa-miR-9-5p | Invasive ductal carcinoma | MNDR-E-MI-72486 |
| MNDR | hsa-miR-9-5p | Glioblastoma | MNDR-E-MI-72487 |
| MNDR | hsa-miR-9-5p | Glioblastoma multiforme somatic | MNDR-E-MI-72488 |
| MNDR | hsa-miR-9-5p | Glioma | MNDR-E-MI-72489 |
| MNDR | hsa-miR-9-5p | Oligodendroglioma | MNDR-E-MI-72490 |
| MNDR | hsa-miR-9-5p | Neurilemmoma | MNDR-E-MI-72491 |
| MNDR | hsa-miR-9-5p | Central nervous system lymphoma | MNDR-E-MI-72492 |
| MNDR | hsa-miR-9-5p | Rhabdomyosarcoma | MNDR-E-MI-72493 |
| MNDR | hsa-miR-9-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-72494 |
| MNDR | hsa-miR-9-5p | Epilepsy temporal lobe | MNDR-E-MI-72495 |
| MNDR | hsa-miR-9-5p | Osteosarcoma | MNDR-E-MI-72496 |
| MNDR | hsa-miR-9-5p | Uterus cancer | MNDR-E-MI-72497 |
| MNDR | hsa-miR-9-5p | Melas syndrome | MNDR-E-MI-72498 |
| MNDR | hsa-miR-9-5p | Cervical adenocarcinoma | MNDR-E-MI-72499 |
| MNDR | hsa-miR-9-5p | Gastric adenocarcinoma | MNDR-E-MI-72500 |
| MNDR | hsa-miR-9-5p | Cervical squamous cell carcinoma | MNDR-E-MI-72501 |
| MNDR | hsa-miR-9-5p | Pituitary adenoma | MNDR-E-MI-72502 |
| MNDR | hsa-miR-9-5p | Lung squamous cell carcinoma | MNDR-E-MI-72503 |
| MNDR | hsa-miR-9-5p | Carcinoma lung non-small-cell | MNDR-E-MI-72504 |
| MNDR | hsa-miR-9-5p | Lung adenocarcinoma | MNDR-E-MI-72505 |
| MNDR | hsa-miR-9-5p | Thyroid carcinoma | MNDR-E-MI-72506 |
| MNDR | hsa-miR-9-5p | Papillary thyroid carcinoma | MNDR-E-MI-72507 |
| MNDR | hsa-miR-9-5p | Brain stem cancer | MNDR-E-MI-72508 |
| MNDR | hsa-miR-9-5p | Cervical cancer | MNDR-E-MI-72509 |
| MNDR | hsa-miR-9-5p | Carcinoma renal cell | MNDR-E-MI-72510 |
| MNDR | hsa-miR-9-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-72511 |
| MNDR | hsa-miR-9-5p | Renal clear cell carcinoma | MNDR-E-MI-72512 |
| MNDR | hsa-miR-9-5p | Large cell carcinoma | MNDR-E-MI-72513 |
| MNDR | hsa-miR-9-5p | Cholangiocarcinoma | MNDR-E-MI-72514 |
| MNDR | hsa-miR-9-5p | Esophageal cancer | MNDR-E-MI-72515 |
| MNDR | hsa-miR-9-5p | Lung small cell carcinoma | MNDR-E-MI-72516 |
| MNDR | hsa-miR-9-5p | Schizophrenia | MNDR-E-MI-72517 |
| MNDR | hsa-miR-9-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-72518 |
| MNDR | hsa-miR-9-5p | Heart failure | MNDR-E-MI-72519 |
| MNDR | hsa-miR-9-5p | Uveal melanoma | MNDR-E-MI-72520 |
| MNDR | hsa-miR-9-5p | Breast invasive carcinoma | MNDR-E-MI-72521 |
| MNDR | hsa-miR-9-5p | Progressive supranuclear palsy | MNDR-E-MI-72522 |
| MNDR | hsa-miR-9-5p | Hepatocellular carcinoma | MNDR-E-MI-72523 |
| MNDR | hsa-miR-9-5p | Embryonal tumors | MNDR-E-MI-72524 |
| MNDR | hsa-miR-9-5p | Familiar ovarian carcinoma | MNDR-E-MI-72525 |
| MNDR | hsa-miR-9-5p | B-cell lymphoma | MNDR-E-MI-72526 |
| MNDR | hsa-miR-9-5p | T-cell leukemia | MNDR-E-MI-72527 |
| MNDR | hsa-miR-9-5p | Neuroblastoma | MNDR-E-MI-72528 |
| MNDR | hsa-miR-9-5p | Hodgkin lymphoma | MNDR-E-MI-72529 |
| MNDR | hsa-miR-9-5p | Burkitt lymphoma | MNDR-E-MI-72530 |
| MNDR | hsa-miR-9-5p | Mouth neoplasms | MNDR-E-MI-72531 |
| MNDR | hsa-miR-9-5p | Acute myelocytic leukemia | MNDR-E-MI-72532 |
| MNDR | hsa-miR-9-5p | Colorectal cancer | MNDR-E-MI-72533 |
| MNDR | hsa-miR-9-5p | Nasopharynx carcinoma | MNDR-E-MI-72534 |
| MNDR | hsa-miR-9-5p | Multiple myeloma | MNDR-E-MI-72535 |
| MNDR | hsa-miR-9-5p | Acute lymphocytic leukemia | MNDR-E-MI-72536 |
| MNDR | hsa-miR-9-5p | Ovarian epithelial cancer | MNDR-E-MI-72537 |
| MNDR | hsa-miR-9-5p | Uterine cervical neoplasms | MNDR-E-MI-72538 |
| MNDR | hsa-miR-9-5p | Ependymoma | MNDR-E-MI-72539 |
| MNDR | hsa-miR-9-5p | Prostatic neoplasms | MNDR-E-MI-72540 |
| MNDR | hsa-miR-9-5p | Aids dementia complex | MNDR-E-MI-72541 |
| MNDR | hsa-miR-9-5p | Epstein-barr virus infections | MNDR-E-MI-72542 |
| MNDR | hsa-miR-9-5p | Gait ataxia | MNDR-E-MI-72543 |
| MNDR | hsa-miR-9-5p | Stroke lacunar | MNDR-E-MI-72544 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | ABCC1 | Homo sapiens | RR00023333 |
TOP